Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Big data in IBD: big progress for clinical practice
Nasim Sadat Seyed Tabib, Matthew Madgwick, Padhmanand Sudhakar, et al.
Gut (2020) Vol. 69, Iss. 8, pp. 1520-1532
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019
Rui Wang, Zhaoqi Li, Shaojun Liu, et al.
BMJ Open (2023) Vol. 13, Iss. 3, pp. e065186-e065186
Open Access | Times Cited: 267
Gut microbiome, big data and machine learning to promote precision medicine for cancer
Giovanni Cammarota, Gianluca Ianiro, Anna M. Ahern, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 10, pp. 635-648
Closed Access | Times Cited: 241
Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis
Yifan Qu, Xinyi Li, Fengying Xu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 199
Breaking the therapeutic ceiling in drug development in ulcerative colitis
Dahham Alsoud, Bram Verstockt, Claudio Fiocchi, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 7, pp. 589-595
Open Access | Times Cited: 128
Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review
Min’an Zhao, Jiayi Chu, Shiyao Feng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114985-114985
Open Access | Times Cited: 115
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities
Nikolas Plevris, Charlie W. Lees
Gastroenterology (2022) Vol. 162, Iss. 5, pp. 1456-1475.e1
Open Access | Times Cited: 90
Artificial Intelligence in Pharmaceutical Sciences
Mingkun Lu, Jiayi Yin, Qi Zhu, et al.
Engineering (2023) Vol. 27, pp. 37-69
Open Access | Times Cited: 64
Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets
Arno R. Bourgonje, Damian Klóska, Anna Grochot-Przęczek, et al.
Redox Biology (2023) Vol. 60, pp. 102603-102603
Open Access | Times Cited: 60
Navigating the complexities of drug development for inflammatory bowel disease
Sailish Honap, Vipul Jairath, Silvio Danese, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 546-562
Closed Access | Times Cited: 24
Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia
Marietta Iacucci, Giovanni Santacroce, Snehali Majumder, et al.
Gut (2024) Vol. 73, Iss. 10, pp. 1749-1762
Open Access | Times Cited: 18
Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease
Marietta Iacucci, Giovanni Santacroce, Irene Zammarchi, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 8, pp. 758-772
Open Access | Times Cited: 15
Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges
Junjie Peng, Elizabeth C. Jury, Pierre Dönnes, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 91
Artificial intelligence in gastroenterology: A state-of-the-art review
Paul T. Kröner, Megan Engels, Benjamin S. Glicksberg, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 40, pp. 6794-6824
Open Access | Times Cited: 91
Stigmasterol Restores the Balance of Treg/Th17 Cells by Activating the Butyrate-PPARγ Axis in Colitis
Shuting Wen, Long He, Zhuotai Zhong, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 88
An AIEgen-based oral-administration nanosystem for detection and therapy of ulcerative colitis via 3D-MSOT/NIR-II fluorescent imaging and inhibiting NLRP3 inflammasome
Lihe Sun, Juan Ouyang, Fang Zeng, et al.
Biomaterials (2022) Vol. 283, pp. 121468-121468
Closed Access | Times Cited: 66
The Inflammatory Bowel Disease Transcriptome and Metatranscriptome Meta-Analysis (IBD TaMMA) framework
Luca Massimino, Luigi Antonio Lamparelli, Yashar Houshyar, et al.
Nature Computational Science (2021) Vol. 1, Iss. 8, pp. 511-515
Open Access | Times Cited: 65
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—Disease Outcome and Response to Therapy
Bram Verstockt, Nurulamin M Noor, Urko M. Marigorta, et al.
Journal of Crohn s and Colitis (2021) Vol. 15, Iss. 9, pp. 1431-1442
Open Access | Times Cited: 60
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach
Brigida Barberio, Sonia Facchin, Ilaria Patuzzi, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 52
The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease
Shengjie Ma, Jiaxin Zhang, Heshi Liu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 50
Artificial Intelligence, Healthcare, Clinical Genomics, and Pharmacogenomics Approaches in Precision Medicine
Habiba Abdelhalim, Asude Berber, Mudassir Lodi, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 48
How Do We Predict a Patient’s Disease Course and Whether They Will Respond to Specific Treatments?
Bram Verstockt, Miles Parkes, James Lee
Gastroenterology (2022) Vol. 162, Iss. 5, pp. 1383-1395
Open Access | Times Cited: 47
Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?
Bram Verstockt, Brian Bressler, Helena Martínez-Lozano, et al.
Gastroenterology (2022) Vol. 162, Iss. 5, pp. 1370-1382
Closed Access | Times Cited: 40
Oleic Acid and Palmitic Acid from Bacteroides thetaiotaomicron and Lactobacillus johnsonii Exhibit Anti-Inflammatory and Antifungal Properties
Rogatien Charlet, Chrystelle Le Danvic, Boualem Sendid, et al.
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1803-1803
Open Access | Times Cited: 39
Validity of Inflammatory Bowel Disease Diagnoses in the Danish National Patient Registry: A Population-Based Study from the North Denmark Region
Henrik Jacobsen, Tine Jess, Lone Larsen
Clinical Epidemiology (2022) Vol. Volume 14, pp. 1099-1109
Open Access | Times Cited: 38
Framework and metrics for the clinical use and implementation of artificial intelligence algorithms into endoscopy practice: recommendations from the American Society for Gastrointestinal Endoscopy Artificial Intelligence Task Force
Sravanthi Parasa, Alessandro Repici, Tyler M. Berzin, et al.
Gastrointestinal Endoscopy (2023) Vol. 97, Iss. 5, pp. 815-824.e1
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top